Area of research
Genetics · Cancer Research
Research interest
Research interests include BRCA gene mutations in cancer, Breast Cancer Treatment Studies, PARP inhibition in cancer therapy, and Advanced Breast Cancer Therapies.
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study
The impact of national non-pharmaceutical interventions (‘lockdowns’) on the presentation of cancer patients
Mortality due to cancer treatment delay: systematic review and meta-analysis